MYUNGMOON Pharm co.,Ltd

KOSE:A017180 Stock Report

Market Cap: ₩63.9b

MYUNGMOON PharmLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for MYUNGMOON PharmLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth31.7%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Is MYUNGMOON PharmLtd (KRX:017180) Weighed On By Its Debt Load?

Sep 06
Is MYUNGMOON PharmLtd (KRX:017180) Weighed On By Its Debt Load?

MYUNGMOON Pharm co.,Ltd's (KRX:017180) 35% Share Price Surge Not Quite Adding Up

Jul 26
MYUNGMOON Pharm co.,Ltd's (KRX:017180) 35% Share Price Surge Not Quite Adding Up

MYUNGMOON PharmLtd (KRX:017180) Has No Shortage Of Debt

Mar 21
MYUNGMOON PharmLtd (KRX:017180) Has No Shortage Of Debt

Does MYUNGMOON PharmLtd (KRX:017180) Have A Healthy Balance Sheet?

Mar 31
Does MYUNGMOON PharmLtd (KRX:017180) Have A Healthy Balance Sheet?

Introducing MYUNGMOON PharmLtd (KRX:017180), A Stock That Climbed 77% In The Last Five Years

Feb 06
Introducing MYUNGMOON PharmLtd (KRX:017180), A Stock That Climbed 77% In The Last Five Years

Does Myungmoon Pharm (KRX:017180) Have A Healthy Balance Sheet?

Dec 15
Does Myungmoon Pharm (KRX:017180) Have A Healthy Balance Sheet?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as MYUNGMOON PharmLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSE:A017180 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/2024180,143-7,574-7,014-5,421N/A
6/30/2024176,368-7,719-4,030-2,714N/A
3/31/2024173,796-6,322-9,165-6,673N/A
12/31/2023169,567-4,525-8,171-5,181N/A
9/30/2023166,6984,140-6,443-3,066N/A
6/30/2023160,3665,172-7,465-3,686N/A
3/31/2023157,6387,4852,0644,613N/A
12/31/2022152,1357,8683,5905,475N/A
9/30/2022147,514-4,7704,2045,084N/A
6/30/2022145,836-4,9987,9808,453N/A
3/31/2022140,778-6,5172,2262,528N/A
12/31/2021137,760-6,865480855N/A
9/30/2021134,608-6,830-11,489-10,636N/A
6/30/2021131,560-11,501-12,031-11,271N/A
3/31/2021125,543-21,751-18,134-16,449N/A
12/31/2020127,853-27,639-18,543-16,672N/A
9/30/2020134,148-32,042-10,893-7,697N/A
6/30/2020141,691-28,654-18,526-11,593N/A
3/31/2020146,936-24,325-15,579-6,108N/A
12/31/2019149,346-20,402-14,143-2,941N/A
9/30/2019152,571-7,612-12,9074,200N/A
6/30/2019147,467-6,687-9,7883,540N/A
3/31/2019149,139-945-1,9268,337N/A
12/31/2018147,49998831411,407N/A
9/30/2018142,3341,569-6,3018,039N/A
6/30/2018142,4692,414N/A14,041N/A
3/31/2018142,6007,672N/A7,985N/A
12/31/2017140,1387,807N/A8,024N/A
9/30/2017139,5097,688N/A7,394N/A
6/30/2017141,9748,471N/A1,659N/A
3/31/2017140,9175,206N/A7,838N/A
12/31/2016142,1806,746N/A5,601N/A
9/30/2016138,775-9,119N/A611N/A
6/30/2016135,216-9,085N/A1,750N/A
3/31/2016130,907-13,359N/A-2,346N/A
12/31/2015125,101-16,135N/A-5,505N/A
9/30/2015121,032-873N/A-3,078N/A
6/30/2015114,633-2,147N/A-4,450N/A
3/31/2015108,932201N/A-2,045N/A
12/31/2014105,421761N/A-36N/A
9/30/2014101,790346N/A241N/A
6/30/2014100,19933N/A6,511N/A
3/31/2014101,352443N/A2,510N/A
12/31/2013103,7231,026N/A2,004N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A017180's forecast earnings growth is above the savings rate (2.7%).

Earnings vs Market: Insufficient data to determine if A017180's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A017180's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A017180's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A017180's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if A017180's Return on Equity is forecast to be high in 3 years time


Discover growth companies